(1553902) Mutations and translocations associated with venetoclax resistance in chronic lymphocytic leukemia (CLL)

Primary Author; Presenting Author(s)

• 

  Kiyomi Mashima, MD, PhD

  Post Doctoral Researcher
  Dana-Farber Cancer Institute
  Boston, MA, United States

  Slides

Co-Author(s)

• YK

  Yanan Kuang, PhD

  Dana-Farber Cancer Institute
  Boston, MA, United States
• SF

  Stacey M. Fernandes, BS

  Dana-Farber Cancer Institute
  Boston, MA, United States
• SS

  Samantha Shupe, BS

  Dana-Farber Cancer Institute
  Boston, MA, United States
• RF

  Rayan Fardoun, BS

  Dana-Farber Cancer Institute
  Boston, MA, United States
• MM

  Mariia Mikhaleva, MD

  Dana-Farber Cancer Institute
  Boston, MA, United States
• AN

  Aishath Naeem, PhD

  Dana-Farber Cancer Institute
  Boston, MA, United States
• BH

  Benjamin Hanna

  Dana-Farber Cancer Institute
  Boston, MA, United States

Co-Author(s)

• CP

  Cloud P. Paweletz, PhD

  Dana-Farber Cancer Institute
  Boston, MA, United States

Co-Author(s)

• 

  Matthew S. Davids, MD, MMSc

  Director, Clinical Research, Division of Lymphoma
  Dana-Farber Cancer Institute (DFCI)
  Boston, MA, United States
• 

  Jennifer R. Brown, MD, PhD

  Director, CLL Center & Institute Physician, DFCI; Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology, HMS
  Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI); Department of Medicine, Harvard Medical School (HMS)
  Boston, MA, United States